Non-halogenated glucocorticoid related to triamcinolone hexacetonide, q.v. with a high ratio of topical to systemic activity. Prepn: R. L. Brattsand et al., DE 2323215; eidem, US 3929768 (1973, 1975 both to Bofors). Synthesis and anti-inflammatory properties: A. Thalén, R. L. Brattsand, Arzneim.-Forsch. 29, 1787 (1979). Pharmacokinetic study: A. Ryrfeldt et al., J. Steroid Biochem. 10, 317 (1979). HPLC determn of epimers, impurities, content: G. Roth et al., J. Pharm. Sci. 69, 766 (1980). Clinical experience in collagenous colitis: S. Miehlke et al., Aliment. Pharmacol. Ther. 22, 1115 (2005). Safety profile in asthma patients: A. L. Sheffer et al., Ann. Allergy Asthma Immunol. 94, 48 (2005). Review of physical and pharmocokinetic properties: E. J. O'Connell, Clin. Ther. 25, C42-C60 (2003); of pharmacokinetics and clinical experience in Crohn's disease: S. Edsbcker, T. Andersson, Clin. Pharmacokinet. 43, 803-821 (2004); in allergic rhinitis: B. E. Stanaland, Clin. Ther. 26, 473-492 (2004); in pediatric asthma: W. E. Berger, Drugs 65, 1973-1989 (2005).
Anti-inflammatory.
Antiasthmatic (Steroidal, Inhalant); Glucocorticoid